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Background: Electrode positioning is important for the operation of implantable loop recorders (ILRs).
This study aimed to investigate optimal electrode positions for the implantation of ILRs.
Methods: Fifteen male subjects participated in the study and R wave amplitude data were collected from
15 areas in the left anterior chest area, with 4 variations of electrode angles and body positions.
Results: The estimated minimum R wave amplitude values were greater than 0.3 mV (manufacturer-
recommended value) when electrodes were angled vertically and positioned on the midclavicular line of
the third and the forth intercostal spaces or on the left sternal border of the fourth and ﬁfth intercostal
space and when angled at 451 to the right on the left sternal border of the third and the forth
intercostal space.
Conclusions: Exploring areas around the left sternal border of the fourth intercostal space – where the R
wave amplitudes are least affected by body positions – is a reliable method for choosing implantation
locations for ILRs.
& 2014 Japanese Heart Rhythm Society. Published by Elsevier B.V. All rights reserved.
1. Introduction
Implantable loop recorders (ILRs) were introduced in Japan in
October 2009 as an effective diagnostic tool for unexplained
recurrent syncope [1–3]. By August 2012, ILRs had been implanted
in approximately 850 patients. Representative randomized trials
explored and provided evidence for their efﬁcacy in patients with
neurally-mediated syncope (NMS), and these include RAST [4]
(Randomized Assessment of Syncope Trial), ISSUE [5–7], and
ISSUE2 [8]. The PICTURE [9] trial revealed the usefulness of early
implantation of ILRs, and the number of cases has increased
remarkably ever since the introductory phase. Furthermore, as
ILRs are smaller in size than other cardiac devices, such as pace-
makers, implantable cardioverter deﬁbrillators, and devices for
cardiac resynchronization therapy, the implantation procedure is
relatively safe.
In order to accurately diagnose the causes of syncope, ILRs
should be implanted in a region with higher R wave amplitude
[10]. However, R wave amplitude often varies depending on body
position, and this can lead to temporary undersensing, resulting in
false diagnoses of bradycardia, cardiac arrest, or chronic R wave
amplitude decrement, all of which demand surgical intervention
[11,12].
At present, the most efﬁcient approach to the selection
of electrode positions is still undetermined; thus, surgical
time is extended while the best position is sought for each
procedure.
In order to reduce surgical duration times and to maintain the
sensitivity and speciﬁcity of ILRs, it is important to characterize
each potential electrode position.
This study investigated the changes in R wave amplitude at
different locations and angles of implanted electrodes, as well as
different body positions of the patient, using a Reveals cardiac
monitor (Medtronic Inc., Minneapolis, MN, USA). The aim was to
locate the optimal position for implantation in order to avoid false
detection of arrhythmias.
Basic information regarding this device is as follows. Distance
between the electrodes is 40 mm, the size of this device is
19628mm. The manufacturer-recommended implant zones are
either between the ﬁrst intercostal space and the fourth rib (the V3
area) or between the fourth and the ﬁfth rib. At these locations it is
possible to obtain an R wave amplitude greater than 0.3 mV.
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2. Materials and methods
Fifteen healthy adult men participated in this study. The left
anterior chest area was subdivided into 15 regions based on
5 longitudinal points (from the second to the sixth intercostal
spaces) and 3 lateral points (including the left sternal border,
midclavicular line, and anterior axillary line) (Fig. 1). The R wave
amplitude was recorded by identifying the center of the simulant
bipolar electrodes in each area by rotating the electrodes to the
vertical axis (A), horizontal axis (B), 451 to the left (C), and 451 to
the right (D) (Fig. 1).
Additionally, each participant assumed 4 body positions:
supine, right lateral, left lateral, and a standing position. When
each point, angle, and body position was combined, the R wave
amplitude was recorded, for a total of 240 patterns per participant.
In addition, there is a ﬂap-electrode attached to the package of
the Reveal DX (Fig. 2), and it is possible to measure the R wave
amplitude using this electrode. However, the ﬂap-electrode is
single-use, and this trial required the measurement of many
patterns; thus, the durability of the electrode was unknown.
Thus, we used a normal disposable electrode with the same
electrode spacing as the Reveal DX to measure the R wave
amplitude in the present study (Fig. 3).
All subjects in this study provided informed and written consent.
3. Results
3.1. Distribution of R wave amplitude
The R wave amplitude data was recorded in each electrode
position and angle for all 15 participants and was analyzed under
the assumption of normal distribution. The data were recorded on
normal probability paper and tested for a good ﬁt. The determina-
tion coefﬁcient was 0.96170.033, and the R wave amplitude data
were assumed to ﬁt a normal distribution pattern.
3.2. Variation of the R wave amplitude in the supine position (mV)
As the R wave amplitude data were considered to be normally-
distributed, minimum amplitude values were estimated by sub-
tracting double the value of the standard deviation from the mean
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Fig. 1. Electrode sites and directions of rotation.
Fig. 2. Measuring method using an electrode included with the Reveal DX.
Fig. 3. Measuring method using a disposable electrocardiogram electrode used in
this experiment.
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value of each participant's R wave amplitude data collected in the
supine position. The estimated minimum amplitude values (Min)
and the mean values were illustrated as cobweb charts and are
presented in Fig. 4. A total of 97.7% R wave amplitudes recorded in
this study had an amplitude greater than the value of the
estimated minimum amplitude.
In addition, the labels 1–15 displayed in Fig. 4 correlate to the
site labels in Fig. 1.
Fig. 4. Variation of the R wave amplitude in the supine position.
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The axes of the cobweb charts represent the angles of the
electrodes (A, B, C, and D respectively correspond to the vertical,
horizontal, 451 left, and 451 right angles as in Fig. 1). The positive
and negative values for each axis of ABCD are also shown. The
minimum value of each axis was 0 mV, and the maximum value
was 1.2 mV, with a scale interval of 0.3 mV.
The area in orange (Fig. 4) represents the R wave amplitude and
is lower than the manufacturer-recommended amplitude
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Fig. 5. The rate of change of the R wave amplitude due to postural change from the supine position.
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(0.3 mV). Moreover, the mean (blue line in Fig. 4) designates the
average value, and Min (red line in Fig. 4) designates the estimated
minimum amplitude.
The estimated minimum amplitude less than 0.3 mV was
observed at every electrode position on the second intercostal
space (1, 2, and 3, regardless of electrode angle) at electrode
positions 5, 6, and 9 (with a horizontal angle) (B).
The mean R wave amplitude value was greatest in area 13 with
angle D (1.46 mV), followed by areas 14D (1.36 mV), 11D (1.27 mV),
13A (1.22 mV), and 10D (1.20 mV). As an overall trend, the area at
Fig. 6. Variation of the R wave amplitude in all body positions.
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the lower intercostal space had a higher R wave amplitude, while
lower values were observed at the lateral position (near the
anterior axillary line) (Fig. 4).
3.3. Rate of change of R wave amplitude due to postural change
originating from the supine position (mV)
Fig. 5 shows the impact of body position on the R wave
amplitude for each electrode position and angle. The thick, black
line represents the base supine position. The scale represents the
differences in R wave amplitudes as measured in each body
position (right lateral position: red line; left lateral position: green
line; standing position: blue line) and compared to the supine
position within a range of 0.5 to þ0.5.
Variation in R wave amplitudes was small at positions 7 and
8 for all angles except horizontal. Relatively less variation was
observed at every area on the left sternal border and the fourth
intercostal space. However, if electrodes were moved superiorly,
inferiorly, or outside of this position, R wave amplitude changed
depending on participants' body positions. If electrodes moved
superiorly, the amplitude increased in the standing position and
decreased in the left lateral position, and vice versa if electrodes
moved inferiorly.
3.4. Variation of R wave amplitude in all body positions
Fig. 6 illustrates variations in the R wave amplitude in each
participant and all body positions. In this cobweb chart, the area in
yellow (0.3 mV) indicates values below the manufacturer-
recommended reference base, the red line indicates the minimum
amplitude (Min), and the blue line represents the mean value
(Mean).
On average, high R wave amplitude was attained at positions 13
and 14 on the sixth intercostal space and at position 11 on the ﬁfth
intercostal space. However, R wave amplitude varied widely in
these electrode positions, and the estimated minimum amplitude
values fell below 0.3 mV. The electrode positions with an esti-
mated minimum amplitude greater than 0.3 mV were 5, 7, 8, and
10 with angle A (vertical) or positions 4 and 7 with angle D (right
451 angle).
4. Discussion
This study aimed to investigate the optimal electrode position
for ILR implantation with a high R wave amplitude and no height
variation, regardless of different body positions and electrode
angles. In the present study, the R wave amplitude data collected
from 15 participants at all body positions and electrode angles
were assumed to be normally distributed. The mean (m) and the
standard deviation (σ) were calculated, and the minimum ampli-
tude value was estimated by subtracting twice the value of the
standard deviation from the mean value (m2σ).
Fig. 7 shows an example of the actual R wave amplitude
distribution attained in this study and the optimal normal dis-
tribution curve calculated by normal probability plotting. Further-
more, the mean and the standard deviation of the optimal normal
distribution curve were calculated and m7σ and m72σ are also
shown in the graph. It was shown that 97.7% of the R wave
amplitude (ﬁlled area) was greater than the estimated minimum
amplitude value (m2σ, in this case 0.144 mV).
Generally, the aforementioned statistics are used with the
estimated minimum amplitude value calculated by subtracting
3σ from the mean value (i.e., 99.9% of the data is greater than this
value). However, if this was followed in the present study, the
electrode positions with an estimated minimum amplitude value
greater than 0.3 mV (manufacturer-recommended value) would
not have existed. Hence, this study accepted m2σ as the
estimated minimum amplitude value.
The amplitude data obtained from subjects in the supine
position had an estimated minimum amplitude value greater than
0.3 mV (although some areas fell slightly below this but within
acceptable limits), with the only exception being the data gathered
at the second intercostal space. Namely, when electrode positions
were investigated in the supine position, all areas except for the
second intercostal space reached acceptable amplitude values.
Additionally, the R wave amplitude was inclined to increase with
electrodes located either on the inferior intercostal space or closer
to the sternum, while right 451 or vertical angles attained higher R
wave amplitudes.
Taking body positions into consideration, the variation ratio of
the R wave amplitude was smallest along the midclavicular line
and the left sternal border of the fourth intercostal space (posi-
tions 8 and 9, respectively). Electrodes were positioned on
exterior, superior, or inferior areas, and R wave amplitude was
affected by body positions.
Thus, if the region for implant was chosen based only on the
height of the R wave amplitude in the supine position, the
electrodes might be located in an area where amplitude varies
as a result of changes to the body position; this in turn could lead
to false diagnoses. In order to avoid this, the most reliable method
for choosing an implant position was presumed to be investigation
of the areas around the left sternal border of the fourth intercostal
space, where the impact of body position was the smallest. R wave
amplitude values should be greater than 0.3 mV regardless of body
position.
5. Conclusion
If the location for ILR implant is chosen based only on the
height of the R wave amplitude in the supine position, the
electrodes could be located in an area where amplitude varies by
changing body positions which could lead to false diagnoses.
Although R wave amplitudes change depending on body positions,
the minimum amplitude value was estimated to be greater than
the manufacturer-recommended value of 0.3 mV on the midcla-
vicular line on the third intercostal space position 5, the left
sternal border on the fourth intercostal space position 7, the
midclavicular line on the fourth intercostal space position 8, and
the left sternal border on the ﬁfth intercostal space position 10,
with electrodes positioned at a vertical angle (A), or on the left
Fig. 7. An example of the actual R wave amplitude distribution attained in this
study and the optimal normal distribution curve, calculated by normal probability
plotting.
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sternal border at positions 4 and 7 on the third and fourth
intercostal spaces at a right 451 angle (D).
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